enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Solriamfetol - Wikipedia

   en.wikipedia.org/wiki/Solriamfetol

   Solriamfetol is used to promote wakefulness in the treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea in adults. [1] It appears to be more effective in improving excessive daytime sleepiness associated with obstructive sleep apnea than certain other wakefulness-promoting agents including modafinil, armodafinil, and pitolisant.

3. Armodafinil - Wikipedia

   en.wikipedia.org/wiki/Armodafinil

   Armodafinil, sold under the brand name Nuvigil, is a wakefulness-promoting medication which is used to treat excessive daytime sleepiness associated with obstructive sleep apnea, narcolepsy, and shift work disorder. [1] It is also used off-label for certain other indications. [10] The drug is taken by mouth. [1]

4. Pitolisant - Wikipedia

   en.wikipedia.org/wiki/Pitolisant

   Pitolisant, sold under the brand name Wakix among others, is a medication used for the treatment of excessive daytime sleepiness in adults with narcolepsy. [3] It is an inverse agonist of the histamine H 3 receptor. [3]

5. Sleep Experts Share 7 Reasons You’re Sleeping So Much - AOL

   www.aol.com/lifestyle/sleep-experts-share-7...

   The two most common health conditions associated with excessive sleepiness are obstructive sleep apnea and narcolepsy, O’Malley says. ... Antihistamines. Benzodiazepines. ... The best gift ...

6. Doxylamine - Wikipedia

   en.wikipedia.org/wiki/Doxylamine

   Doxylamine and other first-generation antihistamines are the most widely used sleep medications in the world. [6] Typical side effects of doxylamine (at recommended doses) include dizziness, drowsiness, grogginess, and dry mouth, among others. [7] [4] As an antihistamine, doxylamine is an inverse agonist of the histamine H 1 receptor.

7. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.